David Parrish expects AI to be among the major talking points for a newly formed committee aimed at protecting the interests ...

Wu Xiaoping of Wanhuida Intellectual Property says the methodology often applied in assessing inventiveness in pharmaceutical ...

A new survey by Arnold & Porter reveals that AI adoption in life sciences is accelerating, driving innovation in drug ...

The tie-up, which will create a firm with a combined revenue of around $2bn, will add around 10 US-based partners to Herbert ...

Maohua Wang, head of the IP group at King & Wood Mallesons in China, explains how the firm’s Eversheds deal affected the IP ...

Strength at the Unified Patent Court was among the factors that drew a life sciences patent litigator to join McDermott Will ...

Lawyers at Dentons unpick the findings of a survey that revealed that businesses tend to focus on reactive rather than ...

In the latest UPC update, we examine a ruling on director liability, another on the Gillette defence, and look ahead to cases ...

Peng Lei and David Webb of Herbert Smith Freehills assess what battery innovators need to know to protect their investments ...

Little to no policies from either candidate suggest we may be waiting a while before we see major changes to the US’s IP ...